{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:00:20Z","timestamp":1772164820747,"version":"3.50.1"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"8","license":[{"start":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T00:00:00Z","timestamp":1661126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kathleen M. Rotz Lung Cancer Research Fund"},{"name":"HHS | NIH | National Cancer Institute","award":["R01-CA057341-28"],"award-info":[{"award-number":["R01-CA057341-28"]}]},{"DOI":"10.13039\/100000060","name":"HHS | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["NIH R01-AI067946-14"],"award-info":[{"award-number":["NIH R01-AI067946-14"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009729","name":"Ludwig Institute for Cancer Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009729","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,22]]},"abstract":"<jats:p>Adoptive cell transfer (ACT) immunotherapy has remarkable efficacy against some hematologic malignancies. However, its efficacy in solid tumors is limited by the adverse tumor microenvironment (TME) conditions, most notably that acidity inhibits T and natural killer (NK) cell mTOR complex 1 (mTORC1) activity and impairs cytotoxicity. In several reported studies, systemic buffering of tumor acidity enhanced the efficacy of immune checkpoint inhibitors. Paradoxically, we found in a MYC\u2013driven hepatocellular carcinoma model that systemic buffering increased tumor mTORC1 activity, negating inhibition of tumor growth by anti-PD1 treatment. Therefore, in this proof-of-concept study, we tested the metabolic engineering of immune effector cells to mitigate the inhibitory effect of tumor acidity while avoiding side effects associated with systemic buffering. We first overexpressed an activated RHEB in the human NK cell line NK-92, thereby rescuing acid-blunted mTORC1 activity and enhancing cytolytic activity. Then, to directly mitigate the effect of acidity, we ectopically expressed acid extruder proteins. Whereas ectopic expression of carbonic anhydrase IX (CA9) moderately increased mTORC1 activity, it did not enhance effector function. In contrast, overexpressing a constitutively active Na+\/H+-exchanger 1 (NHE1; SLC9A1) in NK-92 did not elevate mTORC1 but enhanced degranulation, target engagement, in vitro cytotoxicity, and in vivo antitumor activity. Our findings suggest the feasibility of overcoming the inhibitory effect of the TME by metabolically engineering immune effector cells, which can enhance ACT for better efficacy against solid tumors.<\/jats:p>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study demonstrates the feasibility of metabolic engineering immune effector cells to overcome inhibition in the TME, an approach that could enhance the efficacy of adoptive transfer immunotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-22-0270","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T09:56:08Z","timestamp":1659347768000},"page":"842-856","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Na+\/H+-exchanger 1 Enhances Antitumor Activity of Engineered NK-92 Natural Killer Cells"],"prefix":"10.1158","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3439-0660","authenticated-orcid":true,"given":"Yao-Yu","family":"Gong","sequence":"first","affiliation":[{"name":"1Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongguang","family":"Shao","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5304-6454","authenticated-orcid":true,"given":"Yu","family":"Li","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Columbia University Medical Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4836-7421","authenticated-orcid":true,"given":"Patricia","family":"Brafford","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachary E.","family":"Stine","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean W.","family":"Felsher","sequence":"additional","affiliation":[{"name":"5Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7117-7725","authenticated-orcid":true,"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[{"name":"3Department of Pediatrics, Columbia University Medical Center, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven M.","family":"Albelda","sequence":"additional","affiliation":[{"name":"4Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4031-2522","authenticated-orcid":true,"given":"Chi V.","family":"Dang","sequence":"additional","affiliation":[{"name":"2The Wistar Institute, Philadelphia, Pennsylvania."},{"name":"6Ludwig Institute for Cancer Research, New York, New York."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2022,8,22]]},"reference":[{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/s41417-019-0155-1","article-title":"Challenges in assessing solid tumor responses to immunotherapy","volume":"27","author":"Chai","year":"2020","journal-title":"Cancer Gene Ther"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"e002723","DOI":"10.1136\/jitc-2021-002723","article-title":"Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead","volume":"9","author":"Kirtane","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41571-020-0426-7","article-title":"Exploring the NK cell platform for cancer immunotherapy","volume":"18","author":"Myers","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"3425291","DOI":"10.1155\/2019\/3425291","article-title":"Efficiency of CAR-T therapy for treatment of solid tumor in clinical trials: a meta-analysis","volume":"2019","author":"Hou","year":"2019","journal-title":"Dis Markers"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.apsb.2020.10.020","article-title":"CAR-T cells: early successes in blood cancer and challenges in solid tumors","volume":"11","author":"Dana","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"2023031315422112600_","first-page":"6449","article-title":"Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review","volume":"49","author":"Vaupel","year":"1989","journal-title":"Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/2159-8290.CD-15-0507","article-title":"MYC, metabolism, and cancer","volume":"5","author":"Stine","year":"2015","journal-title":"Cancer Discov"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s10555-019-09792-7","article-title":"Causes, consequences, and therapy of tumors acidosis","volume":"38","author":"Pillai","year":"2019","journal-title":"Cancer Metastasis Rev"},{"key":"2023031315422112600_","first-page":"1284","article-title":"Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism","volume":"8","author":"Helmlinger","year":"2002","journal-title":"Clin Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J Biol Chem"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.semcancer.2017.03.001","article-title":"Cancer acidity: an ultimate frontier of tumor immune escape and a novel target of immunomodulation","volume":"43","author":"Huber","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell\u2013derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1002\/ijc.30646","article-title":"Reversal of tumor acidosis by systemic buffering reactivates NK cells to express IFN-\u03b3 and induces NK cell-dependent lymphoma control without other immunotherapies","volume":"140","author":"P\u00f6tzl","year":"2017","journal-title":"Int J Cancer"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1158\/0008-5472.CAN-15-1743","article-title":"Neutralization of tumor acidity improves antitumor responses to immunotherapy","volume":"76","author":"Pilon-Thomas","year":"2016","journal-title":"Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1158\/0008-5472.CAN-11-1272","article-title":"Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes","volume":"72","author":"Calcinotto","year":"2012","journal-title":"Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1929727","DOI":"10.1080\/2162402X.2021.1929727","article-title":"Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer","volume":"10","author":"Qin","year":"2021","journal-title":"Oncoimmunology"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1371\/journal.pbio.0020332","article-title":"Developmental context determines latency of MYC-induced tumorigenesis","volume":"2","author":"Beer","year":"2004","journal-title":"PLoS Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cell.2018.05.009","article-title":"Acid suspends the circadian clock in hypoxia through inhibition of mTOR","volume":"174","author":"Walton","year":"2018","journal-title":"Cell"},{"key":"2023031315422112600_","first-page":"652","article-title":"Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells","volume":"8","author":"Gong","year":"1994","journal-title":"Leukemia"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1089\/10430349950018030","article-title":"Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy","volume":"10","author":"Tam","year":"1999","journal-title":"Hum Gene Ther"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2017.01.005","article-title":"Characterization of human cancer cell lines by reverse-phase protein arrays","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s42003-019-0393-7","article-title":"Evidence-based guidelines for controlling pH in mammalian live-cell culture systems","volume":"2","author":"Michl","year":"2019","journal-title":"Commun Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1365-2958.2005.04877.x","article-title":"Identification of novel single amino acid changes that result in hyperactivation of the unique GTPase, Rheb, in fission yeast","volume":"58","author":"Urano","year":"2005","journal-title":"Mol Microbiol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"24096","DOI":"10.1074\/jbc.M116.736215","article-title":"A histidine cluster in the cytoplasmic domain of the Na-H exchanger NHE1 confers pH-sensitive phospholipid binding and regulates transporter activity","volume":"291","author":"Webb","year":"2016","journal-title":"J Biol Chem"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"13875","DOI":"10.1038\/srep13875","article-title":"An optimized method for high-titer lentivirus preparations without ultracentrifugation","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1172\/JCI75836","article-title":"Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis","volume":"125","author":"Xiang","year":"2015","journal-title":"J Clin Invest"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jim.2007.05.013","article-title":"A novel multiparametric flow cytometry-based cytotoxicity assay simultaneously immunophenotypes effector cells: comparisons to a 4 h 51Cr-release assay","volume":"325","author":"Kim","year":"2007","journal-title":"J Immunol Methods"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-1-60761-362-6_7","article-title":"Natural killer cell conjugate assay using two-color flow cytometry","volume":"612","author":"Burshtyn","year":"2010","journal-title":"Methods Mol Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-8885-3_7","article-title":"CD107a degranulation assay to evaluate immune cell antitumor activity","volume":"1884","author":"Lorenzo-Herrero","year":"2019","journal-title":"Methods Mol Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cyto.990140810","article-title":"Measurement of intracellular pH using flow cytometry with carboxy-SNARF-1","volume":"14","author":"Wieder","year":"1993","journal-title":"Cytometry"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1038\/s41467-021-23496-z","article-title":"Structure and mechanism of the human NHE1-CHP1 complex","volume":"12","author":"Dong","year":"2021","journal-title":"Nat Commun"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/978-1-4939-6881-7_31","article-title":"Measurement of lytic granule convergence after formation of an NK cell immunological synapse","volume":"1584","author":"Hsu","year":"2017","journal-title":"Methods Mol Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"ra24","DOI":"10.1126\/scisignal.2002739","article-title":"Chronic activation of mTOR complex 1 is sufficient to cause hepatocellular carcinoma in mice","volume":"5","author":"Menon","year":"2012","journal-title":"Sci Signal"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fimmu.2016.00091","article-title":"Natural killer cells for immunotherapy \u2013 advantages of the NK-92 cell line over blood NK cells","volume":"7","author":"Klingemann","year":"2016","journal-title":"Front Immunol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.omto.2021.10.001","article-title":"The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy","volume":"23","author":"Fabian","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00262-015-1761-x","article-title":"NK-92: an \u2018off-the-shelf therapeutic\u2019 for adoptive natural killer cell-based cancer immunotherapy","volume":"65","author":"Suck","year":"2016","journal-title":"Cancer Immunol Immunother"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/onc.2008.362","article-title":"CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations","volume":"28","author":"Smalley","year":"2009","journal-title":"Oncogene"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.4049\/jimmunol.1401558","article-title":"mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function","volume":"193","author":"Donnelly","year":"2014","journal-title":"J Immunol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1038\/s41467-018-07277-9","article-title":"Crosstalks between mTORC1 and mTORC2 variagate cytokine signaling to control NK maturation and effector function","volume":"9","author":"Wang","year":"2018","journal-title":"Nat Commun"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1158\/0008-5472.CAN-14-3283","article-title":"Genetic regulation of fate decisions in therapeutic T cells to enhance tumor protection and memory formation","volume":"75","author":"Veli\u00e7a","year":"2015","journal-title":"Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1172\/JCI77746","article-title":"mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation","volume":"125","author":"Pollizzi","year":"2015","journal-title":"J Clin Invest"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1158\/0008-5472.CAN-11-2520","article-title":"Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors","volume":"71","author":"Ditte","year":"2011","journal-title":"Cancer Res"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"29930","DOI":"10.1074\/jbc.M402591200","article-title":"Regulation of B-raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent","volume":"279","author":"Karbowniczek","year":"2004","journal-title":"J Biol Chem"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1096\/fj.09-149518","article-title":"NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space","volume":"24","author":"Busco","year":"2010","journal-title":"FASEB J"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0021-9258(17)41985-5","article-title":"Evidence that Na+\/H+ exchanger isoforms NHE1 and NHE3 exist as stable dimers in membranes with a high degree of specificity for homodimers","volume":"269","author":"Fafournoux","year":"1994","journal-title":"J Biol Chem"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"10346","DOI":"10.1073\/pnas.0604236103","article-title":"CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells","volume":"103","author":"Chen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12915-016-0252-7","article-title":"The human Na(+)\/H(+) exchanger 1 is a membrane scaffold protein for extracellular signal-regulated kinase 2","volume":"14","author":"Hendus-Altenburger","year":"2016","journal-title":"BMC Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrc2819","article-title":"MYC as a regulator of ribosome biogenesis and protein synthesis","volume":"10","author":"Van Riggelen","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/nature07017","article-title":"Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate","volume":"453","author":"Gallagher","year":"2008","journal-title":"Nature"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"e15691","DOI":"10.7554\/eLife.15691","article-title":"A nonrandomized cohort and a randomized study of local control of large hepatocarcinoma by targeting intratumoral lactic acidosis","volume":"5","author":"Chao","year":"2016","journal-title":"Elife"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"F1187","DOI":"10.1152\/ajprenal.00185.2018","article-title":"Acid-base regulation in the renal proximal tubules: using novel pH sensors to maintain homeostasis","volume":"315","author":"Rajkumar","year":"2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.resp.2018.01.002","article-title":"The effect of metabolic alkalosis on the ventilatory response in healthy subjects","volume":"249","author":"Oppersma","year":"2018","journal-title":"Respir Physiol Neurobiol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fphys.2013.00354","article-title":"Acidic tumor microenvironment and pH-sensing G protein-coupled receptors","volume":"4","author":"Justus","year":"2013","journal-title":"Front Physiol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.3390\/ijms20102378","article-title":"Structural and functional changes in the Na+\/H+ exchanger isoform 1, induced by Erk1\/2 phosphorylation","volume":"20","author":"Fliegel","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2021.11.104","article-title":"The positive feedback loop of NHE1-ERK phosphorylation mediated by BRAFV600E mutation contributes to tumorigenesis and development of glioblastoma","volume":"588","author":"Li","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"609532","DOI":"10.3389\/fcell.2021.609532","article-title":"The role of the cytoskeleton in regulating the natural killer cell immune response in health and disease: from signaling dynamics to function","volume":"9","author":"Ben-Shmuel","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S1097-2765(00)00139-8","article-title":"Direct Binding of the Na\u2013H exchanger NHE1 to erm proteins regulates the cortical cytoskeleton and cell shape independently of H(+) translocation","volume":"6","author":"Denker","year":"2000","journal-title":"Mol Cell"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1083\/jcb.200208050","article-title":"Cell migration requires both ion translocation and cytoskeletal anchoring by the Na-H exchanger NHE1","volume":"159","author":"Denker","year":"2002","journal-title":"J Cell Biol"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/s41467-018-05261-x","article-title":"Systems analysis of intracellular pH vulnerabilities for cancer therapy","volume":"9","author":"Persi","year":"2018","journal-title":"Nat Commun"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1182\/blood.2021011563","article-title":"Proton export alkalinizes intracellular pH and reprograms carbon metabolism to drive normal and malignant cell growth","volume":"139","author":"Man","year":"2022","journal-title":"Blood"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2009-03-209650","article-title":"T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a hodgkin tumor model","volume":"113","author":"Di Stasi","year":"2009","journal-title":"Blood"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.mt.6300404","article-title":"Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies","volume":"16","author":"Huang","year":"2008","journal-title":"Mol Ther"},{"key":"2023031315422112600_","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3389\/fimmu.2019.01906","article-title":"CD8+ T lymphocyte and NK cell network: circuitry in the cytotoxic domain of immunity","volume":"10","author":"Uzhachenko","year":"2019","journal-title":"Front Immunol"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-22-0270\/3184458\/crc-22-0270.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/2\/8\/842\/3282628\/crc-22-0270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/2\/8\/842\/3282628\/crc-22-0270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T01:15:22Z","timestamp":1700874922000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/2\/8\/842\/708157\/Na-H-exchanger-1-Enhances-Antitumor-Activity-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,22]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,22]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-22-0270","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.22544936.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.22544936","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.6550796","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.c.6550796.v1","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,22]]}}}